spacer
home > epc > spring 2009 > seamless systems
PUBLICATIONS
European Pharmaceutical Contractor

Seamless Systems

Pharmaceutical, biotechnology and medical device companies are increasingly outsourcing to specialised contract research organisations  CROs) in order to remain competitive in an increasingly complex global environment. A recent research study published by Business Insights Ltd entitled ‘The CRO Market Outlook: Emerging Markets, Leading Players and Future Trends’ projects an annual growth rate of 14 to 16 per cent for the CRO market, reaching a value of $24 billion by 2010. CROs have been established as full service providers offering focused and expertise-rich solutions for a range of activities, from research and development (R&D) to clinical trials and manufacturing, through to marketing. This substantial growth is driven by the capability of CROs to achieve optimum cost efficiency, manage peak workload, increase global reach and reduce time-tomarket for pharmaceutical companies seeking to maintain their competitive position. In addition, outsourcing takes the burden of non-core activities and transactional tasks off sponsor companies and allows them to focus on their core competencies. However, despite strong growth, the global CRO market continues to face a number of challenges.

In order to bolster their pipelines, pharmaceutical companies are looking beyond traditional small molecules to biopharmaceuticals, using biomarkers to better characterise the effectiveness of their therapies in the clinic, and personalised medicine. One way that pharmaceutical companies are able to remain agile is through outsourcing to CROs. Outsourcing allows pharmaceutical companies to take advantage of CROs’ specialised expertise while experiencing an improved return-oninvestment, not only in financial terms, but also in time savings.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Peter Ketelaar is Vice President, Bioanalytical Laboratory PRA International in Assen (NL). Peter joined PRA in 2005, having formerly working in senior management roles at DSM and Codexis with responsibilities in Europe and Asia Pacific. Peter has extensive pharmaceutical industry experience and is currently responsible for extending PRA’s laboratory activities internationally, as well as co-managing the PRA Business Unit Early Development Services.

Trish Meek is Director of Product Strategy, Life Sciences at Thermo Fisher Scientific. Trish joined Informatics when Thermo Fisher acquired Thru-Put Systems, Inc in June 1999. In her current role, she is responsible for determining the strategy of Thermo Fisher’s current portfolio while identifying new market opportunities within the life sciences sector. Trish has worked for Thermo Fisher for the past nine years in the development, sale, support and marketing of laboratory software. A graduate of Loyola University with a BS in Chemistry, Trish began her career with environmental analysis and chemical vapour deposition research.

spacer
Peter Ketelaar
spacer
spacer
spacer
Trish Meek
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers
 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement